Skip to main content
Shalby Limited logo

Shalby Limited — Investor Relations & Filings

Ticker · SHALBY ISIN · INE597J01018 LEI · 335800RVKD2F29DRCR78 BSE.NS Human health and social work activities
Open in API
Filings indexed 791 across all filing types
Latest filing 2023-01-18 Regulatory Filings
Country IN India
Listing BSE.NS SHALBY

About Shalby Limited

https://www.shalby.org

Shalby Limited is a multi-specialty organization recognized for its expertise in orthopedics and joint replacement surgery. The entity operates a network of facilities offering comprehensive medical services, including cardiology, oncology, neurology, and nephrology. It is distinguished by its high volume of orthopedic procedures and the implementation of the "Zero Technique" for knee replacements, designed to minimize surgical duration and accelerate patient recovery. In addition to clinical care, the organization maintains a presence in the orthopedic implant sector through its manufacturing division, which produces specialized implants and surgical instrumentation. The group focuses on providing tertiary and quaternary care utilizing advanced diagnostic and therapeutic infrastructure to serve a diverse patient base.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings
2023-01-18 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated January 17, 2023, announcing the unaudited standalone and consolidated financial results for the quarter ended December 31, 2022. It contains detailed financial performance highlights such as revenue, EBITDA, profit after tax, EPS, and operational metrics for Q3 FY2023 compared to Q3 FY2022. The document includes management commentary on business performance and strategic initiatives. It is not a full annual or interim report but a quarterly earnings announcement with key financial highlights and commentary. The document length is 8792 characters, which is sufficient for a detailed earnings release but not a full interim report with comprehensive financial statements. Therefore, the document fits the definition of an Earnings Release (ER), which is the initial announcement of quarterly financial results with key highlights only. Q3 2023
2023-01-17 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled as an "Investor Presentation for the Quarter ended 31st December, 2022" and contains detailed financial and operational performance data for Q3 FY2023, including revenue, EBITDA, PBT, PAT, segment performance, and operational metrics. It is addressed to stock exchanges and includes comprehensive slides and charts typical of investor presentations. The document is about 15,000 characters long, indicating it is a full presentation rather than a brief announcement. There is no indication that this is a regulatory filing, earnings release summary, or a report publication announcement. Therefore, the document fits the definition of an Investor Presentation (IP).
2023-01-17 English
Financial Result Updates
Regulatory Filings
2023-01-17 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate submitted under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2022. It is a confirmation certificate from the Registrar and Share Transfer Agent regarding dematerialized/rematerialized securities activity (or lack thereof) during the quarter. The document is a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. It is also not an announcement of voting results, management changes, or capital changes. Given the nature of the document as a regulatory compliance certificate, it fits best under Regulatory Filings (RNS). The document length is 3386 characters, which is relatively short and consistent with a certificate or attestation rather than a full report. Therefore, the appropriate classification is Regulatory Filings (RNS) with high confidence.
2023-01-11 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is a notice announcing the schedule of an investor conference call to discuss the unaudited financial results for the quarter ended December 31, 2022. It includes details about the date, time, participants, and dial-in information for the call. There is no actual financial data or detailed report content included, only an invitation and schedule for the call. According to the classification rules, such a document is best classified as a Call Transcript (CT) category, as it pertains to a conference call about quarterly results. However, since this is only an announcement of the call and not the transcript itself, the best fit is still Call Transcript (CT) because the document is specifically about the conference call event related to earnings. Confidence is high due to clear references to the conference call and quarterly results discussion.
2023-01-11 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.